TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCIF) on Wednesday reported a loss of $1 million in its fiscal second quarter.
The Toronto-based company said it had a loss of 4 cents per share.
The extended-release drug developer posted revenue of $395,700 in the period. Its adjusted revenue was $396,000.
In the final minutes of trading on Wednesday, the company's shares hit 14 cents. A year ago, they were trading at 22 cents.